Back to the main directory
Press Release
- Monthly information on share capital and company voting rights by GlobeNewsWire
- GAMCO Expects to Report Diluted EPS for the Third Quarter 2023 of $0.49 to $0.53 Per Share by GlobeNewsWire
- IO Biotech Announces Three Poster Presentations at the Society for Immunotherapy of Cancer’s (SITC) 38th Annual Meeting by GlobeNewsWire
- Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) by GlobeNewsWire
- United Health Products Reports on FDA Application Status by GlobeNewsWire
- Clearside Biomedical to Participate in a Panel Discussion at the JonesTrading 2023 Healthcare Summit by GlobeNewsWire
- CORRECTION - Covenant Logistics Group, Inc. Announces Timing Of Third Quarter Earnings Release And Conference Call by GlobeNewsWire
- Magic Empire Global Limited Announces Special Interim Dividend of US$0.01 per Ordinary Share by GlobeNewsWire
- Firan Technology Group Corporation (“FTG”) Announces Third Quarter 2023 Earnings Release and Conference Call Dates by GlobeNewsWire
- NOVAGOLD Reports Third Quarter 2023 Financial Results by GlobeNewsWire
- Carriage Services Confirms Continuation of Review of Strategic Alternatives by GlobeNewsWire
- Interfor to Announce Third Quarter Results on November 2, 2023 by GlobeNewsWire
- StoneCo Announces Repurchase Program by GlobeNewsWire
- SLB Launches First-of-Its-Kind, Easy-to-Install Methane Measurement Instrument by BusinessWire
- Wall Street Pepe: Introducing Wall Street Pepe by EQS Group AG
- WISeKey’s subsidiary WISeSat cutting-edge, security-hardened IoT nanosatellite crafted to significantly reduce satellite costs tailored for IoT deployments, gains momentum by GlobeNewsWire
- Communiqué de presse : Sanofi et Teva annoncent une collaboration exclusive pour le traitement des maladies inflammatoires de l'intestin by GlobeNewsWire
- Communiqué de presse : Sanofi et Teva annoncent une collaboration exclusive pour le traitement des maladies inflammatoires de l’intestin by GlobeNewsWire
- L'Etat français accorde 16,4 M€ à Global Bioenergies pour la construction de la première usine au monde d'isobutène biosourcé by GlobeNewsWire
- EQS-News: Newron to present three posters on its clinical program evaluating evenamide in the treatment of schizophrenia at the 36th European College of Neuropsychopharmacology Congress by EQS Group AG
- Baloise adopts its Climate Roadmap by EQS Group AG
- INFICON to Publish its Third Quarter 2023 Results on Thursday, October 19, 2023 by EQS Group AG
- INFICON to Publish its Third Quarter 2023 Results on Thursday, October 19, 2023 by EQS Group AG
- Award for customised LEM headquarters in 'The Hive' technology campus by EQS Group AG
- EQS-News: ENCAVIS AG reduziert 2022 erneut seinen CO2-Fußabdruck by EQS Group AG